ClinicalTrials.gg
RecruitingNCT06296277MEET VENUSUpdated May 28, 2026

Mechanical Ventilation in Surgical Patients

An observational study in Surgery, Ventilator Lung and Postoperative Complications, sponsored by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-28.

Sponsored by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Study summary

This is an investigator-initiated, international, multicenter, prospective, cross-sectional study that aims to 1) describe the incidence and types of postoperative pulmonary complications (PPCs), 2) describe patient demographics, baseline characteristics, and intraoperative ventilation management, 3) describe the occurrence of intraoperative adverse events (IAEs), and 4) their associations with PPCs, 5) assess the practice of intraoperative mechanical ventilation.

Patients will be eligible for participation if: 1) adult and 2) receiving intraoperative ventilation during general anesthesia for surgery. Patients receiving ventilation outside of an operating room as well as patients receiving intraoperative ventilation during extracorporeal life support will be excluded

Read the detailed description

This is an investigator-initiated, international, multicenter, prospective, cross-sectional study The here proposed study aims to 1) describe the incidence and types of postoperative pulmonary complications (PPCs), 2) describe patient demographics, baseline characteristics, and intraoperative ventilation management, 3) describe the occurrence of intraoperative adverse events (IAEs), and 4) their associations with PPCs, 5) assess the practice of intraoperative mechanical ventilation.

Patients will be eligible for participation if: 1) adult and 2) receiving intraoperative ventilation during general anesthesia for surgery. Patients receiving ventilation outside of an operating room as well as patients receiving intraoperative ventilation during extracorporeal life support will be excluded.

The primary endpoint is to report the number of patients with PPCs occurring in the first 5 postoperative days. As secondary endpoint, the practice of mechanical ventilation in patients undergoing general anesthesia for surgery will be ascertained including key intraoperative ventilator characteristics and respiratory system mechanics. Other secondary endpoints will include: incidence and type of IAEs; postoperative complications other than PPCs in the first 5 postoperative days; intensive care unit (ICU) admission and length of stay, hospital length of stay, and hospital mortality on day 28.

Participating hospitals have the flexibility to choose a specific time period for data collection, but it is imperative that this process occurs within 8 weeks from receiving approval by the local Ethics Committee. Furthermore, each participating center will conduct data collection during a predetermined 7-day period. Local investigators will capture data in an electronic case recording form, including patient demographics and baseline characteristics, intraoperative ventilator settings and ventilation parameters, and outcomes.

02

Conditions studied

  • Surgery
  • Ventilator Lung
  • Postoperative Complications
03

In context

Postoperative Complications

1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 251 across 537 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria is the lead sponsor of 37 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients subjected to IMV during general anesthesia for surgery will be included in a consecutive manner

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults; and
  • Receiving intraoperative IMV (via tracheal intubation, or supraglottic device ) during general anesthesia for surgery

Exclusion criteria

Exclusion Criteria:

  • Receiving intraoperative IMV outside of an operating room; and
  • Receiving intraoperative IMV during extracorporeal life support
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intraoperative mechanical ventilation

    Patients subjected to invasive mechanical ventilation (IMV) during general anesthesia for surgery

    Other: Intraoperative mechanical ventilation for surgery

Interventions

  • OtherIntraoperative mechanical ventilation for surgery

    Any IMV during general anesthesia for surgery

06

What researchers measure

Primary outcomes

  1. Postoperative pulmonary complications (PPCs)

    Incidence and type of PPCs

    Time frame: within 5 days after surgery

Secondary outcomes

  1. Intraoperative adverse events (IAEs)

    Incidence and type of IAEs

    Time frame: Intraoperatively

  2. Intraoperative mechanical ventilation practice

    Mechanical ventilation settings in patients undergoing general anesthesia for surgery

    Time frame: Intraoperatively

  3. Postoperative clinical outcome

    Hospital mortality

    Time frame: Postoperatively, on day 28 following surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06296277
Lead sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Collaborators
University Of Perugia, University of Chieti, Medical University of Vienna, The Netherlands Cancer Institute, Monash University
Responsible party
Gianmaria Cammarota (Prof Gianmaria Cammarota, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria) — Principal investigator
First posted
Mar 6, 2024
Start date
Mar 1, 2026
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
May 28, 2026

Study contacts

Gianmaria Cammarota, Prof
Contact
gianmaria.cammarota@uniupo.it
+393213733406
Rachele Simonte, MD
Contact
rachele.simonte@gmail.com
Gianmaria Cammarota, Prof
principal investigator · Università degli Studi del Piemonte Orientale
Rachele Simonte, MD
study director · University Of Perugia
Edoardo M De Robertis, Prof
study director · University Of Perugia
Sabrine N.T. Hemmes, MD
study director · Department of Anesthesiology The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Marcus J Schultz, Prof
study director · Department of Anaesthesia, General Intensive Care & Pain Management, Medical University of Vienna
Salvatore M Maggiore, Prof
study chair · Department of Anesthesiology and Intensive Care, Ospedale SS Annunziata & Department of Innovative Technologies in Medicine and Odonto-stomatology, Università Gabriele D'Annunzio di Chieti-Pescara, Chieti, Italy
Ary Serpa Neto, Prof
study director · Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion